Overview

Cochlear Limited is the world leader in implantable hearing solutions.

In 1982 the company commercialized the world’s first cochlear implant and in 2005 acquired the Swedish bone conduction implant, Baha.

Cochlear is a top 100 company on the ASX with more than 1500 employees located in offices in Australia, Japan, China, HK, Singapore, United States, and throughout Europe.

Business Opportunities ( i.e Corporate Alliances/Partnerships)

Cochlear’s products are sold in more than 80 countries. It is a majority direct distribution business with some distributors operating in smaller markets in Europe, South America and Asia.

Cochlear partners with a range of world class technology providers capturing the latest innovations in industrial design, chip development and digital signal processing.

Technology/Products and Services Description

Cochlear core range of products comprise cochlear and bone conduction implants. Cochlear implants are used by children and adults with a severe to profound sensineural hearing loss and who no longer benefit from hearing aids. The product comprises and internal implant and external speech processor.

Cochlear’s bone conduction implants are used for children and adults with a conductive hearing loss or single sided deafness. Baha comprises a titanium implanted fixture and a small external speech processor.

Competitive Advantages

Cochlear products set the benchmark in hearing performance for implantable hearing solutions and offer the highest product reliability.

Cochlear’s investment in research and investment in cochlear and bone conduction implants is the highest worldwide and reflects in the company’s breakthrough innovation.